Resources | Sebia

This section contains information intended for healthcare professionals. Please certify that you are a healthcare professional.

Yes, I am a healthcare professional

No, I am not a healthcare professional

Please indicate your country of residence:

What language is your preference?

Clinical and Operational Aspects of Measuring Hemoglobin A1c by Capillary Electrophoresis

Webinar

Oct. 18, 2022

Educational Webinar with David G. Grenache, PhD, D(ABCC)
Chief Scientific Officer, TriCore Reference Laboratories

Multiple Myeloma: « 20 » and « 100 » Ratios Cut-off applicable to Sebia FLC assays

Publication

Oct. 14, 2022

The « 20 » and « 100 » Ratios Cut-off can be used in routine with Sebia FLC assays for high-risk smoldering multiple myeloma stratification and for assessing progression to active multiple myeloma or amyloidosis.

Sebia acquires Zeus Scientific

Press Release

Oct. 12, 2022

The strategic acquisition reinforces Sebia’s product portfolio & strategy in autoimmunity

Impact of monoclonal antibody therapies on electrophoresis interpretation in myeloma patients

Webinar

Aug. 04, 2022

Educational Webinar with Dr. Rachel WHEELER

Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies – MDPI – 2019

Publication

Jul. 04, 2022

This special Issue related to newborn screening for Sickle Cell disease and other hemoglobinopathies tried to cover the most widely faced challenges in the field of newborn screening for SCD.